Blockbuster M&A Deals Highlight Big Week for BiotechFebruary 22nd 2011
Two billion-dollar acquisitions boosted shares and shined the spotlight on the biotech sector last week, as Sanofi finally sealed the deal with Genzyme and Aveo struck a major cancer drug licensing deal with Japan's Astellas Pharma.
Medical-Device Giants Snap Up Start-Ups as Biotech IPOs FizzleNovember 30th 2010
Two leading medical-device makers announced separate deals to acquire start-ups to bolster their cardiovascular units, while biotech IPOs struggled in a sign that investor enthusiasm for high-risk companies remains anemic.
China's Center Stage of This Week's Biggest Biotech DealsNovember 8th 2010
Biotech stocks had a quite week as gainers offset decliners, despite a big surge in most major market indexes. The week's biggest deals in the sector signified the increasing importance of the Chinese healthcare market for investors.